Dying patients have Pence’s backing on ‘right to try’ policy
Vice President Mike Pence may have just picked another fight with pharmaceutical companies—one that doesn’t involve drug prices.
Health Care & Life Sciences
Articles
Anthem vows to appeal ruling blocking $48B Cigna purchase
While Anthem said it was “significantly disappointed” by the judge’s order and would seek an expedited appeal, Cigna said only that it “intends to carefully review the opinion and evaluate its options in accordance with the merger agreement.”
Anthem’s $48B bid for Cigna blocked by judge as anticompetitive
The deal, along with Aetna Inc.’s proposed tie-up with Humana Inc., which was blocked last month, was set to reduce the ranks of big U.S. health insurers to three from five and make Anthem the largest by membership.
Local health care facility with 87 employees shutting down
The closure of an Indianapolis residential care facility is expected to result in the loss of 87 jobs, but some of the workers might be able to land employment at the same company.
Holcomb’s HIP 2.0 waiver likely to sail through Washington
The Trump administration and its pick to lead the Centers for Medicare & Medicaid Services are likely to champion the approach behind HIP 2.0—a Medicaid expansion that requires those receiving insurance coverage to have "skin in the game" by contributing financially.
Lilly CEO encouraged by Trump meeting, concerned about Obamacare
Eli Lilly and Co. CEO Dave Ricks said he was encouraged by President Donald Trump’s understanding of the complexities of drug development, yet he’s concerned about risks the industry may face in a fresh overhaul of the U.S. health-care system.
Anthem quarterly profit tops expectations; insurer says it’s ‘well positioned’ for 2017
The company’s quarterly earnings announcement did not mention any new developments in the insurer’s pending, $54 billion acquisition of Cigna—which is under review by a federal judge.
Trump spoils pharma chiefs with no more bad news on drug pricing
For drugmakers, including Indianapolis-based Eli Lilly and Co., a meeting Tuesday with President Donald Trump was a dose of happy pills.
Lawsuit says NCAA, Riddell didn’t educate on head injuries
The NCAA and helmet maker Riddell are defendants in separate class-action lawsuits alleging they failed to protect football players from long-term head injuries and didn't educate them about the risks.
UPDATE: Trump tells drugmakers, including Lilly, their prices are ‘astronomical’
President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
Eli Lilly earnings rise sharply but narrowly miss analysts’ expectations
The Indianapolis-based drugmaker got a revenue boost from a host of new medications but also saw sales fall sharply for some older products.
Get ready for a smoking-hot debate over cigarette taxes
Indiana now has one of the lowest cigarette taxes in the nation. It also has one of the highest smoking rates. Some groups want to decrease the latter in part by raising the former.
Indiana medical marijuana backers take hope in bill hearing
When the Indiana Legislature allowed a Senate committee to hear testimony on a medical marijuana-related bill, some proponents saw a glimmer of hope.
Indiana pain medicine doctor faces 55 felony charges
Dr. Tristan Stonger is accused of operating a “pill mill” in Peru, where he saw as many as 100 patients in a single day. He also had offices in Bloomington and Indianapolis.
Planned Parenthood leader Cockrum stepping down after 15 years
Planned Parenthood of Indiana and Kentucky Inc. is searching for a new president and CEO to succeed Betty Cockrum, who plans to retire in June.
Indiana prison medical chief works for private Illinois firm
The chief medical officer for Indiana's prison system held an overlapping position with a for-profit Illinois company that provides health care to correctional facilities in more than a dozen states, according to a published report.
Former COO of health firm claims discrimination in firing
A former executive at an Indianapolis-based chain of health clinics says he was fired because of his age, race and national origin, and in retaliation because he stood up for one of his female managers.
Lilly buying developer of pain-management drugs for $960M
The Indianapolis-based drugmaker’s purchase of the biotech firm CoLucid Pharmaceuticals will give it access to a late-stage experimental medication for migraine headaches.
Purdue-based firm could change radiation treatments
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
Which physician specialties have the worst burnout?
Doctors are reporting more burnout because of too many bureaucratic tasks, difficult patients and too many hours at work. But not all specialties are hit equally hard.